☆ 4.7 Article

Body Composition Analysis in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease

NUTRIENTS (2023)

Related references

Note: Only part of the references are listed.

Article Endocrinology & Metabolism

Metabolic-Associated Fatty Liver Disease and Sarcopenia

Triada Bali et al.

ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2023)

Add to Collection

Article Endocrinology & Metabolism

Metabolic dysfunction-associated fatty liver disease and the risk of 24 specific cancers

Zhenqiu Liu et al.

Summary: The study suggests that metabolic dysfunction-associated fatty liver disease (MAFLD) is closely associated with an increased risk of multiple cancers, with the effect varying by cancer site. This finding highlights the importance of prioritizing the prevention and management of MAFLD in current cancer prevention strategies.

METABOLISM-CLINICAL AND EXPERIMENTAL (2022)

Add to Collection

Article Surgery

Identification of Preoperative Fat-Free Mass Index for the Prognosis of Curatively Resected Esophageal Cancer

Akikazu Yago et al.

Summary: Fat-free mass index (FFMI) is an important prognostic factor for patients undergoing esophagectomy, with no correlation with other nutritional factors.

WORLD JOURNAL OF SURGERY (2022)

Add to Collection

Article Nutrition & Dietetics

Metabolic-Associated Fatty Liver Disease (MAFLD), Diabetes, and Cardiovascular Disease: Associations with Fructose Metabolism and Gut Microbiota

Karolina Drozdz et al.

Summary: Non-alcoholic fatty liver disease (NAFLD) is a common condition associated with type 2 diabetes (T2DM) and cardiovascular disease (CVD). The new term metabolic-associated fatty liver disease (MAFLD) highlights the bidirectional relationships between NAFLD, T2DM, and CVD. Lifestyle changes and targeting the gut microbiota may be important for NAFLD treatment.

NUTRIENTS (2022)

Add to Collection

Article Medicine, General & Internal

Increased estimated fat-free mass and fat mass associated with improved clinical outcome in heart failure

Israel Gotsman et al.

Summary: The study found that increased body composition indices, including body mass index, fat-free mass index, and fat mass index, were associated with better survival in patients with heart failure. The strongest association was seen with fat-free mass index, showing a graded increase in survival.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2022)

Add to Collection

Review Gastroenterology & Hepatology

MAFLD: Renovation of clinical practice and disease awareness of fatty liver

Takumi Kawaguchi et al.

Summary: MAFLD is a new definition of fatty liver that includes metabolic dysfunctions and is independent of alcohol intake and other causes of liver disease. This concept may have a significant impact on clinical practice and disease awareness.

HEPATOLOGY RESEARCH (2022)

Add to Collection

Article Endocrinology & Metabolism

Association of MAFLD With Diabetes, Chronic Kidney Disease, and Cardiovascular Disease: A 4.6-Year Cohort Study in China

Yebei Liang et al.

Summary: The study investigated the prevalence and incidence of MAFLD and its association with diabetes, CKD, and CVD. MAFLD was found to be associated with higher risks of incident diabetes, CKD, and CVD. Patients with MAFLD combined with excessive alcohol consumption and HBV infection had increased risks of incident diabetes compared with those without fatty liver.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Add to Collection

Review Gastroenterology & Hepatology

Systematic Review: The Impact and Importance of Body Composition in Inflammatory Bowel Disease

Nik Sheng Ding et al.

Summary: This review examines the impact and importance of body composition in inflammatory bowel disease (IBD). The findings suggest that alterations in body composition parameters are common in IBD patients, both during active disease and clinical remission, and are associated with poorer prognoses and treatment outcomes. Further investigation and application of body composition parameters have the potential to improve IBD outcomes in the future.

JOURNAL OF CROHNS & COLITIS (2022)

Add to Collection

Article Gastroenterology & Hepatology

Effect of sarcopenia on survival in patients with cirrhosis: A meta-analysis

Xinxing Tantai et al.

Summary: There is a significant association between sarcopenia and increased mortality risk in patients with cirrhosis, especially in male patients, those with alcohol-associated liver disease, and those with Child-Pugh C cirrhosis. The severity and duration of sarcopenia are correlated with higher mortality rates. Raising awareness about the importance of sarcopenia in patients with cirrhosis is crucial.

JOURNAL OF HEPATOLOGY (2022)

Add to Collection

Review Endocrinology & Metabolism

Sarcopenic Obesity in Children and Adolescents: A Systematic Review

Marcela Zembura et al.

Summary: Sarcopenic obesity (SO) is highly prevalent in children and adolescents and is associated with various adverse health outcomes. There is a need for consensus on the definition, standardized evaluation methods, and age and gender thresholds for SO in different ethnicities in the pediatric population.

FRONTIERS IN ENDOCRINOLOGY (2022)

Add to Collection

Article Cell Biology

The prevalence of low muscle mass associated with obesity in the USA

Dana J. Murdock et al.

Summary: This study aimed to estimate the prevalence of obesity with low lean muscle mass (OLLMM) in adults in the USA. The results showed that OLLMM is a substantial burden in the USA, affecting almost 30 million adults, and its prevalence increases with age and among individuals with prediabetes, type 2 diabetes, non-alcoholic fatty liver disease with fibrosis, or post-bariatric surgery.

SKELETAL MUSCLE (2022)

Add to Collection

Letter Gastroenterology & Hepatology

MAFLD 2022: An ELPA/ALPA/EASO-ECPO joint statement on disease stigma

Gamal Shiha et al.

JOURNAL OF HEPATOLOGY (2022)

Add to Collection

Article Geriatrics & Gerontology

Fat-Free Mass Index as a Surrogate Marker of Appendicular Skeletal Muscle Mass Index for Low Muscle Mass Screening in Sarcopenia

Ryoko Kawakami et al.

Summary: This study aimed to explore the relationship between fat-free mass index (FFMI) and appendicular skeletal muscle mass index (ASMI), as well as the effects of age and obesity. The results showed strong positive correlations between FFMI and ASMI measured by both bioelectrical impedance analysis (BIA) and dual-energy X-ray absorptiometry (DXA), regardless of age and obesity. BIA-measured FFMI can serve as a simple surrogate marker for assessing low muscle mass, and optimal FFMI cutoff values for diagnosing sarcopenia were determined.

JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2022)

Add to Collection

Review Gastroenterology & Hepatology

Prognostic accuracy of FIB-4, NAFLD fibrosis score and APRI for NAFLD-related events: A systematic review

Jenny Lee et al.

Summary: This study synthesized the existing literature on the ability of FIB-4, NFS, and APRI models in prognosticating NAFLD-related events. The results showed that these models have demonstrated good ability to risk stratify patients for liver-related morbidity and mortality, with inconsistent performance in predicting change in fibrosis stage. Further head-to-head studies are needed to validate their performance and refine models for prognosticating NAFLD events.

LIVER INTERNATIONAL (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Pathophysiological Molecular Mechanisms of Obesity: A Link between MAFLD and NASH with Cardiovascular Diseases

Jorge Gutierrez-Cuevas et al.

Summary: Obesity is a global epidemic associated with various comorbidities, such as MAFLD, NASH, and CVD, with T2D being a common link between MAFLD/NASH and CVD. Understanding the underlying pathophysiological mechanisms is crucial for developing effective strategies to prevent and treat these diseases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Review Gastroenterology & Hepatology

Clinical practice advice on lifestyle modification in the management of nonalcoholic fatty liver disease in Japan: an expert review

Yoshihiro Kamada et al.

Summary: NAFLD is the most common cause of chronic liver diseases globally, and Japan's guidelines stress the importance of weight management. Japanese patients have a higher occurrence of PNPLA3 gene polymorphisms and lean NAFLD compared to Western populations.

JOURNAL OF GASTROENTEROLOGY (2021)

Add to Collection

Article Endocrinology & Metabolism

An association between visceral or subcutaneous fat accumulation and diabetes mellitus among Japanese subjects

Hirohide Yokokawa et al.

Summary: The study found a significant association between VFA and SFA with diabetes mellitus in Japanese subjects, especially among women. Multivariate analyses indicated that higher quartiles of VFA or SFA were positively associated with DM.

DIABETOLOGY & METABOLIC SYNDROME (2021)

Add to Collection

Review Gastroenterology & Hepatology

Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020

Katsutoshi Tokushige et al.

Summary: Nonalcoholic fatty liver disease (NAFLD) is a serious public health issue in Japan, with nonalcoholic steatohepatitis (NASH) being a progressive form that can lead to liver cirrhosis and increase the risk of hepatocellular carcinoma. The most common cause of death in NAFLD patients is cardiovascular disease.

JOURNAL OF GASTROENTEROLOGY (2021)

Add to Collection

Article Respiratory System

Fat-Free Mass Index Controlled for Age and Sex and Malnutrition Are Predictors of Survival in Interstitial Lung Disease

Sylvia Rinaldi et al.

Summary: This study aimed to examine the predictive value of body composition measures and nutrition status on survival in fibrotic ILD patients. The results showed that z-FFMI and severe malnutrition were significant predictors of survival, independent of disease severity.

RESPIRATION (2021)

Add to Collection

Article Geriatrics & Gerontology

Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment

Liang-Kung Chen et al.

JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2020)

Add to Collection

Article Gastroenterology & Hepatology

A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

Mohammed Eslam et al.

JOURNAL OF HEPATOLOGY (2020)

Add to Collection

Article Gastroenterology & Hepatology

MAFLD identifies patients with significant hepatic fibrosis better than NAFLD

Sakura Yamamura et al.

LIVER INTERNATIONAL (2020)

Add to Collection

Review Gastroenterology & Hepatology

Epidemiology of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Japan: A focused literature review

Yuichiro Eguchi et al.

JGH OPEN (2020)

Add to Collection

Review Gastroenterology & Hepatology

Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers

Eduardo Vilar-Gomez et al.

JOURNAL OF HEPATOLOGY (2018)

Add to Collection

Review Public, Environmental & Occupational Health

The criteria for metabolic syndrome and the national health screening and education system in Japan

Kazumasa Yamagishi et al.

EPIDEMIOLOGY AND HEALTH (2017)

Add to Collection

Article Gastroenterology & Hepatology

Characteristics of non-obese non-alcoholic fatty liver disease: Effect of genetic and environmental factors

Yasushi Honda et al.

HEPATOLOGY RESEARCH (2016)

Add to Collection

Article Gastroenterology & Hepatology

Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): Recommendation from the working group for creation of sarcopenia assessment criteria

Hiroki Nishikawa et al.

HEPATOLOGY RESEARCH (2016)

Add to Collection

Article Gastroenterology & Hepatology

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

Paul Angulo et al.

GASTROENTEROLOGY (2015)

Add to Collection

Article Cardiac & Cardiovascular Systems

The impact of low preoperative fat-free body mass on infections and length of stay after cardiac surgery: A prospective cohort study

Lenny M. W. van Venrooij et al.

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2011)

Add to Collection

© Peeref 2019-2024. All rights reserved.